Determinants to optimize response to clopidogrel in acute coronary syndrome
about
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.Pharmacogenetics of CYP2C19 genetic polymorphism on clopidogrel response in patients with ischemic stroke from Saudi Arabia.Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty.Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.
P2860
Determinants to optimize response to clopidogrel in acute coronary syndrome
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Determinants to optimize response to clopidogrel in acute coronary syndrome
@en
type
label
Determinants to optimize response to clopidogrel in acute coronary syndrome
@en
prefLabel
Determinants to optimize response to clopidogrel in acute coronary syndrome
@en
P2093
P2860
P356
P1476
Determinants to optimize response to clopidogrel in acute coronary syndrome
@en
P2093
Anna Maria Gori
Anna Vestrini
Claudia Saracini
Rosanna Abbate
Rossella Marcucci
P2860
P356
10.2147/PGPM.S5056
P50
P577
2010-04-08T00:00:00Z